Treatment of complex cervical dystonia with botulinum toxin: Involvement of deep-cervical muscles may contribute to suboptimal responses

Parkinsonism and Related Disorders

Volumn 17, Issue SUPPL. 1, 2011, Pages

  Bhidayasiri, Roongroj ^a,b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botulinum toxin; Cervical dystonia; Complex; Treatment failures

Indexed keywords

BOTULINUM TOXIN;

ADULT; AIRWAY OBSTRUCTION; ANALGESIA; ARTICLE; BLEPHAROSPASM; CASE REPORT; CERVICAL DYSTONIA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC REASONING; DRUG EFFICACY; DRUG RESPONSE; DYSPHAGIA; ESOPHAGUS MANOMETRY; FEEDING DISORDER; FEMALE; HAND TREMOR; HEAD AND NECK DISEASE; HUMAN; MUSCLE HYPERTROPHY; MYALGIA; NECK MUSCLE; PRIORITY JOURNAL; SCOLIOSIS; TORTICOLLIS; WEIGHT REDUCTION;

ADULT; BOTULINUM TOXINS; FEMALE; HUMANS; MIDDLE AGED; NECK MUSCLES; TORTICOLLIS; TREATMENT OUTCOME;

EID: 80054120096     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.06.015     Document Type: Article

References (30)

1. Dauer W.T., Burke R.E., Greene P., Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 1998, 121:547-560.
2. Jankovic J., Leder S., Warner D., Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991, 41:1088-1091.
3. Bhidayasiri R., Tarsy D. Clinical aspects of spasmodic torticollis and their evolution. Spasmodic torticollis 2006, 65-80. Expression Sante, Paris. G. Bouvier, F. de Soultrait, P. Molina-Negro (Eds.).
4. Chan J., Brin M.F., Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord 1991, 6:119-126.
5. Ertekin C., Aydogdu I., Secil Y., Kiylioglu N., Tarlaci S., Ozdemirkiran T. Oropharyngeal swallowing in craniocervical dystonia. J Neurol Neurosurg Psychiatry 2002, 73:406-411.
6. Riski J.E., Horner J., Nashold B.S. Swallowing function in patients with spasmodic torticollis. Neurology 1990, 40:1443-1445.
7. Konrad C., Vollmer-Haase J., Anneken K., Knecht S. Orthopedic and neurological complications of cervical dystonia - review of the literature. Acta Neurol Scand 2004, 109:369-373.
8. Gundel H., Wolf A., Xidara V., Busch R., Ladwig K.H., Jacobi F., et al. High psychiatric comorbidity in spasmodic torticollis: a controlled study. J Nerv Ment Dis 2003, 191:465-473.
9. Consky E.S., Lang A.E. Clinical assessment of patients with cervical dystonia. Therapy with botulinum toxin 1994, 211-223. Marcel Dekker, New York. J. Jankovic, M. Hallett (Eds.).
10. Munchau A., Filipovic S.R., Oester-Barkey A., Quinn N.P., Rothwell J.C., Bhatia K.P. Spontaneously changing muscular activation pattern in patients with cervical dystonia. Mov Disord 2001, 16:1091-1097.
11. Tijssen M.A., Marsden J.F., Brown P. Frequency analysis of EMG activity in patients with idiopathic torticollis. Brain 2000, 123(Pt 4):677-686.
12. Tijssen M.A., Munchau A., Marsden J.F., Lees A., Bhatia K.P., Brown P. Descending control of muscles in patients with cervical dystonia. Mov Disord 2002, 17:493-500.
13. Gelb D.J., Yoshimura D.M., Olney R.K., Lowenstein D.H., Aminoff M.J. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 1991, 29:370-376.
14. Krauss J.K., Loher T.J., Pohle T., Weber S., Taub E., Barlocher C.B., et al. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy. J Neurol Neurosurg Psychiatry 2002, 72:249-256.
15. Mayoux-Benhamou A. Descriptive and functional anatomy of cervical muscles. Spasmodic torticollis: clinical aspects and treatment 2006, 19-37. Expression Sante, Paris. G. Bouvier, F. de Soultrait, P. Molina-Negro (Eds.).
16. Dressler D. Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 2000, 7:713-718.
17. Benecke R., Frei K., Comella C.L. Treatment of cervical dystonia. Manual of botulinum toxin therapy 2009, 29-42. Cambridge University Press, Cambridge. D. Truong, D. Dressler, M. Hallett (Eds.).
18. Tsui J.K., Calne D.B. Botulinum toxin in cervical dystonia. Adv Neurol 1988, 49:473-478.
19. Lee I.H., Yoon Y.C., Sung D.H., Kwon J.W., Jung J.Y. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia. AJR Am J Roentgenol 2009, 192:996-1001.
20. Mayoux-Benhamou M.A., Revel M., Wybier M., Barbet J.P. Computerized tomographical study of dorsal neck muscles for insertion of EMG wire electrodes. J Electromyogr Kinesiol 1995, 5:101-107.
21. Benhamou M.A., Revel M., Vallee C. Surface electrodes are not appropriate to record selective myoelectric activity of splenius capitis muscle in humans. Exp Brain Res 1995, 105:432-438.
22. Mayoux-Benhamou M.A., Revel M., Vallee C. Selective electromyography of dorsal neck muscles in humans. Exp Brain Res 1997, 113:353-360.
23. Cagnie B., Dickx N., Peeters I., Tuytens J., Achten E., Cambier D., et al. The use of functional MRI to evaluate cervical flexor activity during different cervical flexion exercises. J Appl Physiol 2008, 104:230-235.
24. Falla D., Jull G., O'Leary S., Dall'Alba P. Further evaluation of an EMG technique for assessment of the deep cervical flexor muscles. J Electromyogr Kinesiol 2006, 16:621-628.
25. Herting B., Wunderlich S., Glockler T., Bendszus M., Mucha D., Reichmann H., et al. Computed tomographycally controlled injection of botulinum toxin into the longus colli muscle in severe anterocollis. Mov Disord 2003, 19:588-590.
26. Glass G.A., Ku S., Ostrem J.L., Heath S., Larson P.S. Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. Parkinsonism Relat Disord 2009, 15:610-613.
27. Jankovic J., Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990, 40:277-280.
28. Tsui J.K., Eisen A., Stoessl A.J., Calne S., Calne D.B. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986, 2:245-247.
29. Kessler K.R., Skutta M., Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. J Neurol 1999, 246:265-274.
30. Benecke R., Jost W.H., Kanovsky P., Ruzicka E., Comes G., Grafe S. A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 2005, 64:1949-1951.